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Chapter 1 
Introduction 
The United States is facing an obesity epidemic due to more than 30% of the 
population being above 30 on the BMI scale (CDC, 2009; Flegal, Ogden, & Curtin, 
2010). No state met the Healthy People 2010 objective of less than 15% obesity 
prevalence (CDC, 2009).  Obesity prevalence has increased in Washington State steadily 
from 1999 – 2009 by nearly a percentage point each year and the fastest growth rate for 
obesity is between ages 18-34 (Washington State Department of Health, 2009). 
Obesity and being overweight are associated with chronic diseases, including type 
2 diabetes, cardiovascular disease, hypertension, and certain forms of cancer that result in 
premature death (Washington State Department of Health, 2009; Williams, et al., 1992; 
World Health Organization, 2003).  Due to the relationship among cardiorespiratory 
fitness, body composition, and physical activity, a person who develops one or more of 
the previous diseases often will die sooner if they are obese compared to those who were 
not obese (Lohman et al., 2008).   
While obesity measured by BMI by is suggestive of risk, fat distribution appears 
to be a more important variable than total body fat in terms of risk for cardiovascular 
disease (Glaner, Lima, & Borysiuk, 2010).  Because greater fat mass around the trunk 
region is generally associated with this higher a measurement of the trunk region should 
prove useful in screening people (Glaner, Lima, & Borysiuk, 2010). Both men and 
women with higher waist to hip ratios have shown stronger associations to encounter 
cardiovascular disease even when controlling for BMI, cancer and/or smoking (Hafe, 
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Pina, Tavares, & Barros, 2004, Lapidus et al., 1984; Larson et al., 1984; Oppert et al., 
2002). 
Values of waist WC are consistently related to developing coronary heart disease 
(CHD), while both the lowest and highest categories of WC remain significant after 
adjustment for BMI for predicting CHD and diabetes (Klein et al., 2007).  The WC 
measurement itself is important and can be combined with BMI as The American College 
of Sports Medicine in their Guidelines for Exercise Testing and Prescription (2010) 
recommend combining a WC with BMI for the purpose of risk stratification.  ACSM 
acknowledges that BMI and WC can be used separately but still recommends using BMI 
and WC when it is an option because abdominal obesity is a primary issue for being an 
indicator of being at health risk (ACSM, 2010). 
Abdominal adiposity has been designated as an independent cardiometabolic 
disease risk factor (Janiszewski, Janssen, & Ross, 2007, Klein et al., 2007, & Ross et al., 
2008) among other risk factors such as age, hypertriglyceridemia, hypertension and high 
fasting glucose, a group of risk factors that when combined increase risk exponentially, 
called metabolic syndrome (Després, Lemieux, Bergeron, Pibarot, Mathieu, Laros et al., 
2008, Ford & Giles, 2003).  Abdominal obesity is a risk factor because there is 
subcutaneous fat (SAT) that is under the skin and deeper fat called visceral fat (VAT), 
which surrounds the organs.  The amount of visceral fat that can accompany abdominal 
obesity is what puts a person at risk for metabolic syndrome.  Every one-centimeter 
incremental increase in waist circumference (WC) has shown increases of 6.8 cm2 of 
visceral adipose tissue (VAT) in men and 3 cm2 of VAT in women, who have metabolic 
syndrome (Onat et al., 2004).   
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As an external measure, WC cannot distinguish between SAT and VAT, but 
currently there are several measurement techniques that can, including Computed 
Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound (US).  VAT is 
an important factor in screening for cardiometabolic disease risks and WC is an 
affordable and time efficient alternative to CT, MRI, and US, to indirectly measure VAT 
in people (Bosy-Westphal et al., 2010, Carr et al., 2004). Ultrasound has been shown to 
be valid in older adults when compared to an MRI (Rolfe, et. al., 2010; Stolk, Wink, 
Zelissen, Van Gils, & Grobbee, 2000).  Tanita has the BC-418 Segment body 
composition analyzer (Tanita, Tokyo, Japan) that has a trunk measure of percent body fat 
estimation, which has been validated against dual energy x-ray absorptiometry (DEXA) 
(Pietrobelli, Rubiano, St-Onge, & Heymsfield, 2004).     
The American Heart Association (AHA), National Cholesterol Education 
Program (NCEP), National Heart Blood and Lung Institute (NHLBI), National Institutes 
of Health of Health (NIH) and the International Diabetes Foundation (IDF) all have WC 
in their screening guidelines, and these organizations believe that WC should be used to 
help screen people for risk of having or getting cardiometabolic disease (Carr et al., 2004; 
Serviente & Sforzo, 2013).  Unfortunately, these organizations and other organizations 
there is no clear or consistent way to perform a WC measurement due to different 
protocols using different sites for what is considered a person’s waist.  The three main 
sites used for WC are below the lowest rib, level at the umbilicus, and superior to the 
iliac crest and the other two sites that can be used are minimal waist and midway between 
the lowest palpable rib and the iliac crest (ACSM, 2010; Serviente & Sforzo, 2013).  The 
issue with different WC sites and one set of cut off points is that this leads to 
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misclassification of people by placing more people in an at risk category due to the WC 
at the level of the umbilicus when compared to minimal waist (Willis et al., 2007). 
 Obesity has become a problem that needs to be addressed in the United States.  
Obesity itself is not as important as the abdominal obesity a person carries, more 
particularly VAT.  There are 5 different WC sites used with only one set of cut-off points 
for all 5 WC sites (Serviente & Sforzo, 2013).  No studies have tried to find a correlation 
of VAT between WC and US or WC and BIA.   If it is possible to determine which of the 
various WC sites have the strongest correlation with a measure of VAT, than that site 
could be the recommended measurement and could start a standardization protocol for 
WC.  Therefore, the purpose of this study is to assess if there is a correlation between any 
of the three main WC sites and either BIA and/or ultrasound. 
Hypothesis 
 H0:  There will be no significant correlations between three waist circumference 
sites: below the lowest rib; at the level of the umbilicus; and superior to the iliac crest; 
with BMI; BIA trunk; or US VAT depth. 
 Ha:  There will be a significant positive correlation between three waist 
circumference sites: below the lowest rib; at the level of the umbilicus; and superior to 
the iliac crest; with BMI; BIA trunk; and US VAT depth.  
Operational Definitions 
BIA: Trunk % fat was measured by the TANITA BC-418 Segmental Body 
Composition Analyzer.  
Body Mass Index:  Body mass index (BMI), the ratio of height to weight was 
determined using weight in kilograms divided by height in meters squared. 
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SCAT & VAT:  BodyMetrix portable ultrasound was used to assess SCAT, and 
VAT depth. 
Waist circumference:  The three waist measurements, just below the lowest 
palpable rib, at the level of the umbilicus, and superior to the iliac crest were 
measured using a Gulick tape.    
Assumptions 
For body composition measurement with BIA, it is important that the subject is in 
a rested and hydrated state.  It is assumed that the subjects will refrain from exercise 
24hrs prior to testing and normal fluid intake is maintained for accurate readings. 
Delimitations 
The population will be delimited to 72 subjects consisting of men and women ages 18 - 
55 that were divided into groups of overweight, BMI score ≥ 26 kg/m2 to 29.9 kg/m2 and 
a obese, BMI score ≥ 30 kg/m2.   
Summary 
This chapter presented the problem of obesity and the implications for being over fat in 
the United States and how Washington State has been affected by the obesity problem 
and more important than obesity is VAT depth. The primary purpose of this study was to 
determine the relationship between waist circumference measurements and ultrasound 
and BIA. Currently, there is no standard for waist circumference measurements.  This 
research was a step towards scientifically choosing an appropriate waist circumference 
site. 
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Chapter 2 
Review of Literature 
Introduction 
 The purpose of this research was to determine the relationship between waist 
circumference measurements and ultrasound and BIA to help further research toward a 
standard protocol for waist circumference measurements.  A review of the current 
literature will cover the implications and risks for being over fat and measurement issues 
around obesity, and how WC may help with screening people for certain disease risk 
factors.   
 Implications for being over fat 
The need of effective interventions to reduce obesity and related health risks have 
increased in recent decades due to obesity levels in adults and children have reached 
epidemic proportions.  The modern environment allows people easier access to make 
unhealthy choices that result in an increased consumption of food, and reduced physical 
activity.  Population approaches for obesity, strive to promote energy balance and 
physical activity (Kumanyika, Obarzanek, Stettler et al., 2008).    This all started in the 
late 1980’s.   
Between 1960 and 1974 the age adjusted prevalence of obesity only increased 
1.1% using the National Health and Nutrition Examination Survey I (NHANES) data 
(CDC, 2008). It was not until NHANES III took place from 1988-1994 that the first big 
increase in obesity prevalence in the United States was found, which was an average 
increase of 8% among men and women (Flegal, Ogden, & Curtin, 2010).  This was 
probably the beginning of the obesity epidemic in the United States.  From 1980-2000 
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obesity prevalence has more than doubled in the US.  This is important because by 1980 
obesity prevalence was estimated at 15% and by 1994 an 8 % increase was observed 
bringing obesity prevalence to 23.2 %.  The next increase (7.5%) lead to a 30.9% obesity 
prevalence suggesting that the rate of obesity may be slowing down due to a lower 
percentage increase than before (CDC, 2008; Flegal et al., 2010).  Even though the 
prevalence of obesity may be slowing down, the United States is still currently facing an 
obesity epidemic due to more than 30% of the population being above 30 on the BMI 
scale nationally, not one state met the Healthy People 2010 objective, which was to have 
less than 15% obesity prevalence (CDC, 2009).  Less than 15% obesity prevalence may 
have been too big of a goal because by 2008 the age-adjusted prevalence of obesity (BMI 
≥ 30.0) was 33.8% overall in the United States (Flegal et al., 2010).  In Washington State 
alone, obesity prevalence has increased steadily from 1999 – 2009 by nearly a percentage 
point each year with the fastest growth rate for obesity in the age group 18-34 meaning 
that the younger generation in Washington state could face bigger health problems and 
higher health care cost if they do not take control over their obesity rate (Washington 
State Department of Health (DOH), 2009).   
The rising prevalence of obesity is important because there are implications that 
go along with obesity.  Obesity, and also being overweight are associated with chronic 
diseases, including type 2 diabetes, cardiovascular disease, hypertension and high total 
cholesterol, and certain forms of cancer that result in premature death (DOH, 2009; 
Williams, et al., 1992; World Health Organization, 2003).  There is a relationship that 
exists between a person’s cardiorespiratory fitness, body composition, and physical 
activity, and the relationship is, that a person who develops one or more of the previous 
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diseases, often will die sooner if they are obese compared to those who are not obese 
(Lohman et al., 2008).  The prevalence of obesity may actually be higher than reported 
because a lot of the population studies use self reported data (CDC, 2009). 
In 2009, self reported body mass index scores (BMI) and body weight of 
Americans lead to an obesity prevalence of 26.7% across America (CDC, 2009). That is 
7.2 percentage points lower than the 2007-2008 NHANES report of 33.9% (CDC, 2009).  
The discrepancy is probably from self-reported data versus actually measuring people for 
accurate data. 
  Validity of self-reported height, weight, and BMI from the NHANES survey 
from 2001-2006 was tested (Merrill & Richardson, 2009) and the results help explain 
why the CDC report statistics that may have obesity prevalence predicted lower than it 
may actually be.  The researchers who tested the validity of self reported data found that 
both men and woman over report their height increasingly at older ages. Men over report 
their height by 1.22cm (0.48 in) and women over report height by .68cm (0.27 in).  Men 
have a tendency to overestimate their weight by .30kg (.66lbs) while women under 
reported their weight by about -1.39 kg (-3.06 lbs) (Merrill & Richardson, 2009).  
Although these examples appear to be minimal in values, over reporting height and 
weight will have a direct impact on a BMI score. An example being that if a man 
overestimates his height (about .5 inch) and weight (about .5lb) than a self reported 6’ 
male weighing 220.5lbs would have a BMI score of 29.9 placing him in the overweight 
category when in reality he is 5’ 11.5” weighing 220lbs, his actual BMI score would be 
30.3 placing him in the obese category.  Male or female, if they are close to a cut off 
point there is an opportunity for misclassification by self-reporting information.   
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Mortality risk appears to vary by BMI categories.  Using NHANES surveys, a 
significant increase in all-cause mortality in the underweight and obese categories were 
observed, while significant decrease in all-cause mortality was observed in the 
overweight category when compared to the normal weight groups (Flegal, Graubard, & 
Williamson, 2005).  In a follow up study the authors estimated excess all-cause mortality 
associations with underweight, overweight, and obesity in the United States using data 
from the NHANES surveys (Flegal, Graubard, Williamson, & Gail, 2007).  The follow 
up involved information from the NHANES I, 1971-1975; II, 1976-1980; and III, 1988-
1994, with mortality follow up through the year 2000, combined with underlying cause of 
death information for 2.3 million adults 25 years and older from the 2004 vital statistics 
data for the United States (Flegal et al., 2007).  Mortality was split into cardiovascular 
disease (CVD) mortality, cancer mortality and noncancer, non-CVD mortality.    
In 2004 cardiovascular disease accounted for 37% of adult deaths in the United 
States (Flegal et al., 2007).  For CVD mortality, obesity, but not overweight, was 
significantly positively associated with excess mortality.  A person’s level of fitness 
influences their body weight.  Usually more active people have lower body weight or 
body fat which is why higher levels of physical fitness appear to delay all-cause mortality 
due primarily to lower rates of cardiovascular disease (Blair et al., 1989). During a 
secondary analysis (Flegal et al., 2007) where CVD was split to coronary heart disease 
(CHD) and deaths from other cardiovascular events including strokes, obesity was 
significantly associated with increased mortality from both CHD (45,544 excess deaths; 
95% CI, 24,785-66,303) and other forms of CVD (34,097 excess deaths; 95%CI, 
213,848-54,346). Based on mortality rates of CVD cases, a person classified as over 
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weight (BMI 25- < 30) maybe should not be instructed by healthcare professionals to lose 
weight or gain any further weight.    
Cancer accounted for approximately 24% of total deaths in adults in the United 
States (Flegal et al., 2007).  For cancer mortality there was little or no significant findings 
or associations of excess mortality with any BMI category (Flegal et al., 2007) 
Noncancer, non-CVD deaths accounted for approximately 39% of total deaths among 
adults in the United States in 2004 (Flegal et al., 2007).   
When the sample was split to underweight and obese, the underweight group of 
the noncancer, non-CVD mortality category, was associated with significantly positive 
number of excess deaths while the overweight group had a significantly negative number 
of excess deaths.  Jiang He and colleagues found similar results when they reported the 
association between being underweight had an increased risk of death which remained 
significant after exclusion of study participants who were current or former smokers; 
those who had prevalent CVD, stroke, cancer, or end-stage renal disease; those who had 
chronic obstructive pulmonary disease at the baseline examination; or those who died 
during the first three years of follow-up (He et al., 2005).  Obese groups were not 
associated with any significant findings, positive or negative, in excess noncancer, non-
CVD mortality.  Having no cancer conditions and no CVD events and being underweight 
(BMI < 18.5) a person may want to try to gain weight for decreased mortality especially 
in women because underweight women had a higher relative risk of mortality than 
underweight men but moderately/extremely obese women had a lower relative risk of 
mortality than men in the same category (Flegal et al., 2007; He et al., 2005; Strawbridge, 
Wallhagen, & Shema, 2000). 
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People who rate on a cutoff point may think they are not endangered or at risk of 
the diseases associated with being obese, which is why we need an accurate way to 
measure adipose tissue (Flegal et. al. 2005).  It is important not to put emphasis on 
obesity because if you force the public or scare the public to lose weight they could place 
themselves in harms way as they get older by trying to maintain low BMI scores 
(Strawbridge et al., 2000). 
Measurements 
 There are various measurement devices used in body composition research.  Some 
instruments are less expensive and also time efficient such as calculating a BMI score and 
measuring WC which is relatively easy to do and can be completed in a variety of 
settings.  Other instruments, such as a bioelectrical impedance analysis (Tanita BC-418 
Segmental Body Composition Analyzer) and a portable ultrasound (IntelaMetrix, Inc., 
Livermore, CA) are usually found in research settings and they cost more, not time 
efficient, and require someone to administer the assessment which makes these options 
less ideal for large populations. 
BMI.   
Body mass index (BMI) is an index that places a person in a classification of 
weight status that varies from underweight to obese.  The BMI calculation is weight in 
kilograms divided by the square of height in meters (kg/m2).  The calculation does not 
use age or the gender of a person in the equation (CDC, 2008; WHO, 2008). 
The various classifications of BMI are as follows; Underweight <18.50, Normal 18.50-
24.99, Overweight ≥25.00, Obese ≥ 30.00.  The obese classification has three different 
classes which are Obese class I 30.00-34.99, Obese class II 35.00-39.99 and Obese class 
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III ≥ 40.00.  The WHO has recognized and is still continuing research on the possibility 
of establishing different cutoff points for different ethnic groups.  The WHO is 
responding to more evidence that suggest the association between BMI, body fat 
distribution, and percentage of body fat may differ across different populations.  The 
focus has been on the breakpoint for the Overweight classification ≥ 25.00.  Health risk 
may increase below this cutoff due to populations who have lower body weights but 
higher body fat percentages, for example Asian and Pacific Islander populations (WHO. 
2004).   
The WHO expert consultation team acknowledged the Pacific Islander population 
as well for having a low proportion of fat mass to lean mass but still have some of the 
highest rates of obesity in the world (WHO, 2004).  The recommendation is that all 
populations with a predisposition to central obesity and have an increased risk for 
developing metabolic syndrome should include a waist circumference measurement as 
well (WHO, 2004).  Further research is needed to address BMI with waist circumference 
in various populations to generate new standards.  BMI has been combined with waist 
circumference in the past. 
BMI with Waist Measurement.  
  Using data from the 1999-2004 NHANES, researchers sought to see if WC could 
in fact predict diabetes and cardiometabolic risk factors beyond that explained by BMI 
alone (Janiszewski et al., 2007).  After inclusion of BMI and cardiometabolic risk factors 
and controlling for age, sex, race and smoking, WC still remained significant in medium 
to high WC measurements for predicting diabetes in this population (Janiszewski et al., 
2007). The relation between WC and clinical outcome is consistently strong for diabetes 
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risk, and WC is a stronger predictor of diabetes than BMI alone (Klein et al., 2007).  
Values of WC are also consistently related to developing CHD, while both the lowest and 
highest categories of WC remain significant after adjustment for BMI for predicting CHD 
and diabetes (Klein et al., 2007). 
BMI and waist circumference (WC) independently help with predicting body fat 
on a person.  Waist circumference has been correlated to total fat mass R2 = 0.87 women 
and 0.68 for men but BMI has shown a stronger correlation with total fat mass R2 = 0.92 
women and 0.78 for men (Janssen, Heymsfield, Allison, Kotler, & Ross, 2002).  The 
American College of Sports Medicine in their Guidelines for Exercise Testing and 
Prescription (9ed) recommend combining a WC with BMI for the purpose of risk 
stratification.  ACSM acknowledges that BMI and WC can be used separately but still 
recommends using BMI and WC when it is an option because abdominal obesity is a 
primary issue for being an indicator of being at health risk (ACSM, 2010).  No 
organization has yet adopted a standard protocol for determining which WC should go 
with BMI.      
Waist Circumference. 
 Abdominal adiposity is a cardiometabolic disease risk factor (Janiszewski et al., 
2007; Klein et al., 2007; Ross et al., 2008) among other risk factors such as age, 
hypertriglyceridemia, hypertension and high fasting glucose (Després et al. 2008, Ford & 
Giles, 2003).  Every 1cm increment in WC has shown increases of 6.8cm2 of VAT in 
men and 3cm2 of VAT in women, who have metabolic syndrome (Onat et al., 2004).  WC 
compared to computerized tomography (CT) in women has shown that WC to intra-
abdominal fat volume had a correlation of 0.889 (Han, McNeil, & Lean, 1997). WC itself 
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cannot distinguish between SAT and VAT but VAT is an important factor in screening 
for cardiometabolic disease risks and WC is an affordable and time efficient alternative to 
CT or MRI to indirectly measure visceral adipose tissue (VAT) in people (Bosy-
Westphal et al., 2010, Carr et al., 2004).   
Besides cardiometabolic disease, cardiovascular disease and type 2diabetes have 
also been linked to high WC measurements.  The population used was 5,882 people from 
the NHANES III.  Individuals with high WC were 73% more likely to have 
cardiovascular disease than individuals with lower WC but after controlling for 
cardiometabolic risk factors the interaction was not significant.  After controlling for 
cardiometabolic risk factors and including BMI, WC predicted type 2 diabetes in medium 
to high WC measurements meaning that WC in this study predicted type 2 diabetes but 
not cardiovascular disease (Janiszewski et al., 2007).  Others have found that in both men 
and women with higher waist to hip circumferences have shown stronger associations to 
encounter CVD even when BMI, cancer, and smoking are controlled for (Lapidus, 
Bengtsson, Larson, Pennert, Rybo, & Sjostrom, 1984; Larson, Svärdsudd, Welin, 
Wilhelmsen, Björntorp, & Tibblin, 1984; Oppert, Charles, Thibult, Guy-Grand, 
Eschwége, & Ducimetiére, 2002).  
There is no consensus on the most appropriate WC measurement technique and 
the American Heart Association (AHA), National Heart Blood and Lung Institute 
(NHLBI), National Institutes of Health (NIH) and the International Diabetes Foundation 
(IDF) all have WC in their screening guidelines.  This causes confusion for exercise 
professionals and allied health care workers as to which site and protocol to use or even if 
it matters (Serviente & Sforzo, 2013) These organizations believe that WC should be 
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used to help screen people for risk of having or getting cardiometabolic disease (Carr et 
al., 2004, Serviente & Sforzo, 2013).  Intra-abdominal fat has been independently 
associated with all of the metabolic syndrome criteria (Carr et al., 2004).  While they all 
agree that WC should be done between these organizations there is no clear or definite 
way to perform a WC measurement due to different protocols using different sites for 
what is considered a person’s waist.  The American College of Sports Medicine (ACSM) 
has recommended one set of cut off points for WC measurements and they are >102 cm 
for men and >88 cm for women which places them in a high risk category (ACSM, 
2007).  The downfall to these cut off points is that various organizations use different 
sites to measure WC to obtain these measurements, causing either more people to be 
placed at high risk or less people to be placed at high risk, depending on the site used.   
WC current recommendations.  
 The WHO recommends that the WC measurement be made at the approximate 
midpoint between the lower margin of the last palpable rib and the top of the iliac crest 
(WHO, 2008).  ACSM recommends using the narrowest part of the torso (ACSM, 2010).  
The AHA, NHLBI and NIH recommend the point superior to the iliac crest (Cornier, 
Després, & Davis, 2011, NHLBI, 1998, NIH, 2000).  The IDF offers different cut off 
points for various parts of the world but they offer no protocol to be used (IDF, 2006).     
Difference between sites. 
In terms of body fat and not disease risk, all five WC sites (measured at 
immediately below the lowest rib, narrowest waist, midpoint between the lowest rib and 
the iliac crest and immediately above the iliac crest) were compared to DEXA and found 
that the WC site superior to the iliac crest had the highest correlation to total body fat in 
		
16	
men and women (Wang et al., 2003).  No matter which site is chosen, each WC 
measurement appears to be reliable (Mason & Katzmarzyk, 2009). 
When following specific instruction, there is good reliability for all measures.  
Intraobserver reliability via intra class correlations were r = .989, r = 0.991, r = 0.992, 
and r = 0.993 for the following WC sites in order; the narrowest part of the waist, 
midpoint between the iliac crest, and below the lowest rib, at the level of the umbilicus, 
and immediately above the iliac crest in 542 predominantly white men and women aged 
20-67 years old (Mason & Katzmarzyk, 2009).  Corresponding ICCs for interobserver 
reliability were r = 0.989, r = 0. 987, r = 0.987, r = 0.987 suggesting the magnitude of the 
WC measurement is influenced by the protocol chosen, more so in women than in men 
(Mason & Katzmarzyk, 2009).  In men and women the highest mean values have been 
reported at the umbilicus site and the smallest mean at the narrowest (Mason & 
Katzmarzyk, 2009). Similar results were found in 111 subjects using the same WC sites, 
researchers determined that men measured at the narrowest part of the waist lead to a WC 
mean that was significantly smaller than the other three sites, but females, the mean for 
each site was significantly different from all other means from the other sites (Wang et 
al., 2003).  The various WC sites are reliable no matter which site is used, but the sites 
themselves differ in magnitude and small differences are amplified when an exact cut off 
point is used, rather than a continuum, to define abdominal obesity (Mason & 
Katzmarzyk, 2009; Wang et al., 2003).  It is important to take into consideration as to 
which site to choose, otherwise you may have a conservative estimate or liberal estimate 
(especially in women) who may be at risk for obesity and this is why adopting a standard 
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measurement protocol will facilitate the interpretation and clinical utility of WC for 
obesity-related risk stratification (Mason & Katzmarzyk, 2009)  
 Currently, major health organizations such as the NHLBI use the cut off points of 
men WC ≥ 102cm and women WC ≥ 88cm (NHLBI, 1998).  The controversy of these cut 
off points is that they were developed using the WC site midway between the lowest rib 
and the iliac crest (Lean, Han, & Morrison, 1995).  NHLBI recommends using the WC 
site superior to the iliac crest but uses cut offs that were developed from a different site 
(NHLBI, 1998).  The cut off points of men WC ≥ 102cm and women WC ≥ 88cm were 
derived from a big sample (904 men & 1014 women) in Glasgow, Scotland and are based 
on the association with BMI and WC (Lean et al., 1995).  The research was for weight 
management and the key messages were that most men with a waist circumference ≥ 102 
cm and women with a waist circumference ≥ 88cm were appreciably overweight or had a 
high waist to hip ratio and should be urged to lose weight and men with WC 94-102 cm 
and women with a WC 80-88 cm should be careful to avoid more weight gain (Lean et 
al., 1995).  The practice of using cut off points based only on BMI and on one WC site 
and interchangeably using those cut off points for other WC sites may lead to a lot of 
misclassifications of people who may need to know if they are at risk of disease (Wang et 
al., 2003). 
 With one set of cut off points for all five WC sites, using the various WC sites 
could lead to misclassification of obesity.  In men and women the highest mean values 
have been reported at the umbilicus site and the smallest mean at the narrowest waist so 
using these sites your (Mason & Katzmarzyk, 2009). 
		
18	
An example of misclassification of health risk is a study that compared the minimal waist 
and the umbilical sites (Willis et al., 2007).  Instead of using BMI (Lean et al., 1995) 
researchers used intravenous glucose tolerance test, fasting plasma lipid analysis and 
computed tomography scans were conducted.  In both men and women the minimal waist 
site had stronger correlations to cardiovascular disease risk factors and metabolic 
syndrome than the umbilicus site.  Using the Adult Treatment Panel (ATP) III criteria 
and using the cut off points of men WC ≥ 102cm and women WC ≥ 88cm, the site used 
made a difference.  Using the umbilical site with these cut off points, it placed 54% more 
men and 68% more women at or above the cut off points (Willis et al., 2007). 
 Comparing umbilicus, midpoint between the lowest rib and the iliac crest, 
superior to the iliac crest and minimal waist sites, to find out if a measurement site will 
affect cardiometabolic risk classification using the cut off points of men WC ≥ 102cm 
and women WC ≥ 88cm (Lean et al., 1995), researchers tested each of these sites for 
sensitivity and specificity (Mason & Katzmarzyk, 2010). In both sexes, WC at the 
umbilicus showed greater sensitivity but less specificity meaning better at predicting the 
presence of disease and not as good as showing absence of disease. (Mason & 
Katzmarzyk, 2010, Serviente & Sforzo, 2013).  Measurements at the minimal waist 
showed less sensitivity but greater specificity at detecting ≥ 2 risk factors for 
cardiometabolic disease.  Using the widely accepted cut off points of men WC ≥ 102cm 
and women WC ≥ 88cm (Lean et al., 1995), the magnitude of WC is affected by the 
measurement site chosen.  Using minimal waist for the men, only placed 23% of them 
into high health risk (>102 cm) while using the umbilicus site, 34% of the men met >102 
cm.  In women 31% were > 88cm and using the minimal waist site and the umbilicus site 
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placed 55% of the women above 88 cm (Mason & Katzmarzyk, 2009).  This variation 
demonstrates the need to have a single WC measurement site and cut off points to go 
with that site to classify people in a health risk category. 
 As far as choosing the site to pick for standardization protocol for WC there is an 
even bigger debate than interchanging cut off points for different sites.  Currently there is 
no agreement on the absolute best site for WC (Serviente & Sforzo, 2013).  Three WC 
sites (below the lowest palpable rib, superior to the iliac crest and midway between the 
lowest rib and the iliac crest) have been tested to see if a site is better than another based 
on volume of VAT and SAT from a MRI, along with cardiometabolic risk factors such as 
blood pressure, plasma lipids, homeostasis model (HOMA index) and glucose (Bosy-
Westphal et al., 2010).  After a dietary intervention, below the lowest palpable rib was 
the only site that predicted weight loss associated with a decrease in VAT, but in women 
only.  The site superior to the iliac crest had very low association with VAT and 
cardiometabolic risk factors in women.  In men and children all three sites had similar 
relations to VAT, SAT and cardiometabolic risk factors (Bosy-Westphal et al., 2010).  
The site below the lowest palpable rib showed the best correlations to pick a site for both 
sexes in terms of total VAT and cardiometabolic risk factors (r = 0.74 men, r = 0.70 in 
women) and men midway between the lowest palpable rib and the iliac crest had similar 
results as the lowest palpable rib site (Bosy-Westphal et al., 2010). 
 In men CT has shown that at L1-L2 and L2-L3 have significantly higher 
correlations (R2  = 0.96, P < 0.05) with total volume of fat and lower SEEs than all other 
images taken by CT scans from T11-S1 (Kuk, Church, Blair, & Ross, 2006).  Women 
that were measured at the midway between the lowest rib and the iliac crest were 
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compared to MRI and CT scans and 2/3 of the distance instead of midway showed r = 
0.99 for predicting intra-abdominal fat (Han et al., 1997).  These previously described 
studies give evidence to the need to identify the best site of WC to predict disease risk.   
 Although WC has been shown to be highly reliable across all sites and WC has a 
strong correlation to body fat, cardiovascular disease and metabolic syndrome risk factors 
there is still no standard protocol and some WC measurements may miss classify more 
people than other WC sites (Klipstein-Grobusch, Georg, & Boeing, 1997; Mason & 
Katzmarzyk, 2010, & Wang et al., 2003; Willis et al., 2007).  VAT is an important factor 
in screening for cardiometabolic disease risks and WC is an affordable and time efficient 
alternative to CT or MRI to indirectly measure VAT in people (Bosy-Westphal et al., 
2010, Carr et al., 2004).  There are other instruments that can measure the trunk region as 
well.    
BIA. 
Bioelectrical Impedance Analysis (BIA) is a noninvasive method that is used to evaluate 
a person’s body composition.  BIA measures the bioelectrical impedance of the body by 
applying a low-level electrical current through the body. The Tanita Body Composition 
Analyzer uses a high frequency constant current (50kHz, 500uA). Fat mass allows 
minimal electrical current to pass through where as water allows electrical current to flow 
through with little resistance, especially in the human body where the water content tends 
to hold electrolytes which are also great conductors of electricity (Heyward & Wagner, 
2004).  The electrical resistance measured or impedance, measured in BIA is the 
difficulty with which electricity passes through the body.  Body fat percentage, muscle 
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mass and total body water can be inferred by measuring the electrical resistance of the 
body. 
 BIA has seen a lot of changes in the last 25 years due to technological advances.  
The original BIA method, which is still used, involves placing electrodes at the wrist and 
ankles.  This method alone has opened up numerous research opportunities involving 
standardizing placement of electrodes, various frequency’s used, and the errors associated 
with subjects in various hydration states (Baumgartner, Chumlea, & Roche, 1989, 
Houtkooper, Lohman, Going, & Howell, 1996).  In one study, the original style BIA with 
applied electrodes was used and still good correlations (r = 0.88) were found to computed 
tomography (CT) (Ryo et al., 2005).   
The first non-clinical method involved a lower body analyzer made available for 
home use in 1992 (Heyward & Wagner, 2004). Leg to leg BIA devices have shown to be 
more reliable than hand held versions when compared to Air Displacement 
Plethysmography (ADP) (Peterson, Repovich & Parascand., 2011). Some devices such as 
the BIA 310 (Biodynamics, Seattle) are portable devices where an electrode is wrapped 
around the wrist and the ankle, and this method has been validated to ADP, and 
hydrostatic weighing (HW) (Biaggi et al., 1999).  The next method developed by Omron 
Healthcare, was a handheld upper body BIA device created in the 1990s for home use 
(Heyward & Wagner, 2004).  Various companies that made the lower body analyzers 
also manufactured full body analyzers where a person stands on electrode plates while 
holding a handle, which also contain electrodes in each hand, and a segmental BIA 
(SBIA) reading is given in addition to the whole body composition value.  Recently, 
Tanita has manufactured the BC-418 Segment body composition analyzer (Tanita, 
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Tokyo, Japan) which is a multi frequency octo-polar model, which has been validated 
against dual energy x-ray absorptiometry (DEXA) (Pietrobelli et al., 2004).  Multi 
frequency octo-polar models have shown to be in closer agreement to DEXA than single 
frequency eight electrode models and single frequency four-polar electrode models 
(Demura, Sato & Kitabayashi., 2004).  In one study it was reported that a multi frequency 
BIA with eight electrodes displayed a difference in which men had an over estimation of 
percent total body fat and women were underestimated in percent total body fat but there 
still was not a significant difference between DEXA or hydrostatic weighing (Demura, et 
al., 2004).  It is unclear if there is a sex characteristic or degrees of obesity responsible for 
the over estimation of body fat percentage in men, and the under estimation of body fat 
percentage in women from the octopolar model (Demura, et al., 2004).   
Being obese or severely obese has been discussed as being a limitation when 
using BIA, which has consistently overestimated lean body mass in severely obese 
people (Segal, Loan, Fitzgerald, Hodgdon & Itallie, 1988).  This could be due to the fact 
that impedance is proportional to length and inversely proportional to diameter so a 
severely obese person who may have more hydration especially in the trunk region due to 
being obese and is going to have a low impedance reading for the trunk and the total 
body water may be shown lower than what it really is (Deurenberg, 1996) even though 
the trunk has been shown to contribute about 10 percent of total impedance for the whole 
body (Bracco et al., 1996).  Over hydration of fat free mass and body shape may be what 
causes FFM to be overestimated and therefore body fat is than under estimated. As long 
as a person is in a normal hydrated state for accurate readings, BIA has been effective at 
estimating total body fatness and segmental body fatness when compared to other clinical 
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methods (Peterson et al., 2011; Pietrobelli et al., 2004; Ryo et al., 2005). All of these 
methods rely on the same principles and all are subject to the same validity issues and 
limitations.  BIA like other methods in body composition research has limitations.  
Quantity and distribution of water within the human body may cause the impedance to 
change.  When a person decides to use a BIA device it is important to be at a normal 
hydrated state (Heymsfield, Wang, Visser, Gallagher, & Pierson Jr, 1996; Houtkooper, 
1996).  Exercise may leave a person in a dehydrated state and food intake all have an 
effect of causing the electrical resistance to be inaccurate, thereby allowing for inaccurate 
BIA readings (Houtkooper et al., 1996). 
Ultrasonography. 
 The basic technology of ultrasound or ultrasonography requires the human body 
to be exposed to high-frequency sound waves which in turn, produce an image of the 
inside of the body. Ultrasound (US) is a relatively new method used in body composition 
research, and recently a portable US has arrived on the market to measure SAT and VAT 
(Ulbricht et al., 2012).  When comparing results to other body composition measurement 
tools in a variety of populations, strong correlations were found (Johnson, Naccarato, 
Corder, & Repovich, 2012; Pineau, & Bocquet, 2009; Ribeiro-Filho, Faria, Azjen, 
Zanella, & Ferreira, 2003; Rolfe, et. al., 2010; Stolk et al., 2001).  Even while on a 
restricted diet similar results have been reported with adolescents between ultrasound and 
DEXA after a six-month weight loss program (r = 0.95) (Pineau et al., 2010).  In addition 
to measuring body composition, a secondary benefit of US is the ability to measure VAT.  
The ability of US to assess VAT has been validated against other measurement tools 
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(Johnson et al., 2012; Ribeiro-Filho et al., 2003; Rolfe, et. al., 2010; Rolfe, et al., 2011; 
Stolk et al., 2001).  
Summary  
 The obesity epidemic is relevant to the work force and many organizations and 
companies have started programs to help address the epidemic.  Since many 
organizations are attempting to approach the obesity epidemic, easy to use, reliable and 
valid methods need to be implemented to measure many people. Clinical assessment 
methods are not accessible by the public and are expensive.  Due to cost and access, field 
measurements are commonly used to make measurements and estimates of body 
composition in order to help people identify where they fall in terms of weight and 
obesity.   
 Simple field measurements like BMI and WC measurements have been useful due 
to low cost and efficiency.  Ultrasound is available to the public in an affordable form 
and ultrasound has been shown to be valid in older adults when compared to an MRI. 
Both men and women with higher waist to hip circumferences have shown stronger 
associations to encounter CVD even when BMI, cancer and smoking are controlled for.  
Excessive trunk fat due to obesity is a risk factor for cardiovascular disease and WC is a 
simple screening tool that can be implemented.  Currently, there is no one protocol or 
WC site that is a standard.  WC and ultrasound have not been tested to see if a correlation 
may exist in visceral fat depth and the various WC sites to help determine if a site may be 
a better choice over another site. 
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Chapter 3	
     Methods 
The purpose of this study was to compare waist circumference sites to ultrasound 
and BIA. Specifically to see if a relationship exist between visceral fat depth from 
ultrasound and the trunk measure from the BIA to the three different waist 
circumferences used.  This chapter provides a description of the methodology that was 
used to test the hypotheses for the current study. This chapter provides a background of 
the participants, information on the instrumentation, an overview of the procedures, and a 
description of the statistical analyses that will be performed. 
Participants 
 The participants consist of men and women within the ages of 18-55 and were 
divided by an overweight group with at least a BMI score ≥ 26 kg/m2 and an obese group 
with a BMI score of ≥ 30.  The participants were recruited through flyers and word of 
mouth from around and in Eastern Washington University and the surrounding 
community.  Table one features descriptive statistics. 
Table 1. descriptive Statistics for the entire sample and subgroups. 
 
Variable ALL  
 
n = 72 
Men 
 
n = 33 
Men 
Overweight 
n = 16 
Men 
Obese 
n = 17 
Women 
All       
n = 39 
Women 
Overweight 
n = 23 
Women 
Obese  
n = 16 
Age 22.8   ± 
5.2 
23.6   ± 
3.5 
23.5  ±   
2.8 
23.7 ± 
4.1 
22.2  ± 
6.3 
20.6   ±  
1.4 
24.4   ± 
9.4 
Height 
(in) 
66.2   ± 
4.1 
70.1   ± 
3.1 
70.1  ±  
3.9 
69.9  ± 
2.3 
64.1 ± 
2.5 
64.0   ±  
2.5 
64.2   ± 
2.5 
Weight 
(lbs) 
202.1 ± 
40.6 
219.9 ± 
28.5 
201.8 ± 
20.8 
237.0 ± 
24.1 
187.0 ± 
43.4 
165.4  ± 
17.1 
218.2  ± 
50.9 
BMI 31.7   ± 
5.7 
31.4   ± 
3.8 
28.5  ±  
0.1 
34.1 ± 
3.6 
31.9 ± 
6.9 
28.3   ±  
1.2 
37.20  ± 
8.2 
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Instrumentation 
 The following variables were recorded for each participant in order to conduct 
this study:  age, gender, height, weight, BIA segment analysis of the trunk, ultrasound 
visceral fat depth, and three standard waist circumference measurements in cm. 
 Anthropometric measurements of height in inches were taken using a beam scale 
equipped with a level (Detecto Physician Scale, Cardinal Scale Manufacturing Co., Webb 
City, MO).  Waist circumference was measured using a Gulick tape measure.  A multi-
frequency BIA (Tanita BC-418 Segmental Body Composition Analyzer) was used for an 
assessment of % fat in the trunk.  Visceral and subcutaneous fat levels were measured 
with a BodyMetrix (IntelaMetrix, Inc., Livermore, CA) portable ultrasonography 
machine. 
Procedure 
After obtaining approval from Eastern Washington University’s Institutional 
Review Board, recruitment started.  Testing was administered in the Human Performance 
Lab.  Once the person agreed to be a participant, height and weight were self-reported to 
find their BMI score, to assure they match the standard body composition of BMI ≥ 26. 
Once they were prescreened, they were scheduled for testing.  All subjects turned in the 
signed informed consent at the testing session. 
 To verify BMI score, height was measured on the standiometer (Detecto 
Physician Scale, Cardinal Scale Manufacturing Co., Webb City, MO) Next, BIA trunk fat 
%, BMI, and body weight in pounds were measured and calculated by the TANITA BC-
418.  The principle investigator entered the subjects’ age, body type (standard for all 
subjects) and height from standiometer reading.  The subjects were instructed to step onto 
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the BIA device bare foot, covering the feet plates to have their body composition 
assessed.  When the BIA was set up with the subjects information, the principle 
investigator instructed the subject to abduct their arms while holding the hand held 
attachments and covering the metal inserts in the handles, while the reading takes place.  
After the measurements were made, the subject replaced the handle attachments and 
stepped off of the BIA device.  All body composition data was made available to the 
subject at the time of testing and after all the data was collected. 
 Following BIA procedures, the subjects underwent three different waist 
circumference measurements.  Subjects were instructed to have their abdominal area to 
be accessible for the principle investigator.  The first waist circumference measurement 
was below the lowest palpable rib.  The lowest rib was palpated to ensure location of the 
landmark.  Once the landmark was located, the principle investigator wrapped a Gulick 
tape measure around the subject’s abdomen at that level while making sure the tape 
remained flat all the way around the subject.  The tension bar was pulled, the 
measurement was recorded rounded to the nearest .5cm and recorded on a separate data 
collection sheet.  The procedure was repeated for the second waist circumference 
measurement taken at the level of the umbilicus.  The last waist circumference 
measurement was taken superior to the iliac crest following the same procedure.  After all 
three waists circumferences were recorded, the principle investigator repeated all three 
measurements in the same order to ensure reliability.  After the second round of 
measurements, if any site was not within .5cm, additional measurements were taken until 
two readings were within .5cm, and an average was computed for the final reading used.  
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 The last procedure was an ultrasound scan of the abdomen using the BodyMetrix 
portable ultrasound device.  The Ultrasound gel is used to enhance conduction for the 
ultrasound wand.  To perform the ultrasound reading to assess visceral and subcutaneous 
fat levels, the gelled wand was placed on the abdomen perpendicular and 1cm to the right 
side of the umbilicus.  Slowly moving the wand 7-10 cm towards the hip completed the 
abdomen scan.  The software included with the BodyMetrix device does not calculate the 
measurement depths for visceral and subcutaneous fat but the tissue types were visible on 
the accompanied computer screen.  The greatest depth was determined by the principle 
investigator and recorded on the data sheet. 
Analysis    
 Statistical analysis was performed using SPSS version 23 (SPSS Inc., Chicago, 
IL).  Data was screened for outliers.  Descriptive statistics were reported including the 
subject’s age, BMI, BIA, height, VAT, waist circumference sites, and weight.  The 
results are presented in table 1.  Pearson’s r correlations were used to determine the 
relationship that exists between the three different waist circumference measurements and 
BMI, BIA, and ultrasound.     
Summary 
 The purpose of this experiment was to compare waist circumference sites to 
ultrasound and BIA. Specifically to see if a relationship exist between visceral fat depth 
from ultrasound and the trunk measure from the BIA to the three different waist 
circumferences.  This chapter presented the methods and statistical analysis used in the 
study. 
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Chapter 4 
Results 
 
The purpose of this study was to see if a relationship might exist between the 
visceral fat depth from ultrasound and the trunk measure from the BIA to the three 
different waist circumferences used.  This chapter provides a summary of the results from 
the statistical analysis depicted in the previous chapter. 
Descriptive Statistics 
 After recruitment 255 people responded.  After prescreening only 75 participants 
completed testing.  Three participants did not meet the criteria on day of testing so they 
were excluded leaving the total sample size to n = 72.  The means and standard 
deviations for the descriptive statistics are displayed in Table 1.  
Pearson’s Correlation 
The sample was broken down into overweight (BMI ≥ 26.0 – 29.0) and obese (≥ 30.0) 
groups for each gender.  Table 2 contains the r values for the entire sample.   
Table 2. entire sample r values, n = 72. 
Variable WC1 WC2 WC3 BMI BIA US 
WC1 - .904** .208 .843* .166 .253* 
WC2 .904** - .241* .862** .415** .531** 
WC3 .208 .241* - .162 .155 .196 
BMI .843** .862** .162 - .418** .407** 
BIA .166 .415** .155 .418** - .693** 
US .253* .531** .196 .407** .693** - 
*p < .05, **p < .01 
BMI showed a strong significant correlation to WC1 (r = .843, p = < .01) and WC2 (r = 
.862, p = < .01).  BMI had little relationship to WC3.  BMI had significant but low              
correlations to BIA (r = .418, p = < .01) and US (r = .407, p = < .01).  BIA had a 
significant but low correlation (r = .415, p = < .01) to WC2.  WC1 and WC3 had no 
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correlations to BIA.  Only WC2 (r = .531, p = < .01) had a significant moderate 
correlation to ultrasound.  The H0 is rejected for BMI to WC1 and WC2 and accepted for 
WC3.  For BIA the H0 is rejected for WC2 and accepted for WC1 and WC3.  For US the 
H0 is rejected for WC1 and WC2 and accepted for WC3.  When the sample was than 
broken down into overweight (BMI ≥ 26.0-29.9) and obese (≥ 30) groups.  Table 3 
contains the r values for the overweight group that contains males and females. 
Table 3. overweight (BMI ≥ 26.0-29.9) men and women for the entire sample, n = 39 
Variable WC1 WC2 WC3 BMI BIA US 
WC1 - .739** .754** .495** -.876 -.221 
WC2 .739** - .954** .571 .251 .350* 
WC3 .754** .954** - .534** .145 .289 
BMI .495** .571** .534** - .256 .136 
BIA -.187 .251 .145 .256 - .727** 
US -.221 .350* .289 .136 .727** - 
 *p < .05, **p < .01 
BMI had a significant but low correlation to WC1 (r = .495, p = < .01) and significant but 
moderately correlated to WC2 and WC3 sites (WC2 r = .571, p = < .01, WC3 r = .534, p 
= < .01).  BIA showed a significant and high correlation (r = .727, p = < .01 to US.  Only 
WC2 showed a significant but low correlation (r = .350, p = < .05) to US.  For BMI the 
H0 is rejected for all three WC sites.  For BIA the H0 is accepted for all three WC sites.  
For US the H0 is rejected for WC2 and accepted for WC1 and WC3. The BMI and WC 2 
should be used together.  Table 4 shows the obese group for the entire sample. 
Table 4. all obese (BMI ≥ 30) people of the entire sample, n = 33 
Variable WC1 WC2 WC3 BMI BIA US 
WC1 - .879** .107 .853** .345* .240 
WC2 .879** - .153 .867** .609** .518** 
WC3 .107 .153 - .042 .205 .173 
BMI .853** .867** .042 - .640** .349* 
BIA .345* .609** .205 .640** - .692** 
US .240 .518** .173 .349* .692** - 
*p < .05, **p < .01 
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WC1 (r = .853, p = < .01) and WC2 (r  = .867, p = < .01) were the only sites strongly 
correlated to BMI. BIA had a significant but low correlation (r = .345, p = < .05) to WC1 
and WC2 had a significant but moderate correlation (r = .609, p = < .01).  US to WC2 
had the only correlation and it showed a significant but moderate correlation (r = .518, p 
= < .01).  For BMI the H0 is rejected for WC1 and WC2 and accepted for WC3.  For BIA 
the H0 is rejected for WC1 and WC2 and accepted for WC3.  For US the H0 is rejected for 
WC2 and accepted for WC1 and WC3.  Next the data was separated by gender.  Table 5 
shows the r values for the males as one group. 
Table 5. all males, n = 33 
Variable WC1 WC2 WC3 BMI BIA US 
WC1 - .956** .956** .868** .867** .686** 
WC2 .956** - .983** .858** .869** .779** 
WC3 .956** .983** - .876** .857** .785** 
BMI .868** .858** .876* - .759** .669** 
BIA .867** .869** .857** .759** - .721** 
US .686** .779** .785** .669** .721** - 
*p < .05, **p < .01 
BMI was significant and highly correlated to all three WC sites (WC1 r = .868, p = < .01, 
WC2 r = .858, p = < .01, WC3 r  = .876, p = < .01).  All three WC sites (WC1 r = .867, p 
= < .01, WC2 r = .869, p = < .01, WC3 r = .857, p = < .01) were significantly and highly 
correlated to the BIA.  WC1 (r = .686, p = < .01) had a significant but moderate 
correlation to US.  WC2 (r = .779, p = .01) and WC3 (r = .785, p = < .01) show 
significant and highly correlated to US.  For BMI, BIA, and US, the H0 is rejected in all 
three WC sites.  All the males were than broken down into the underweight (BMI ≥ 26-
29.9) category and obese (BMI ≥ 30) category.  Table 6 shows the r values for the 
overweight category for males only. 
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Table 6. all overweight (BMI ≥ 26-29.9) males, n = 16 
Variable WC1 WC2 WC3 BMI BIA US 
WC1 - .929** .951** .336 .705* .543* 
WC2 .929** - .956** .388 .736** .673** 
WC3 .951** .956** - .324 .742** .637** 
BMI .336 .388 .324 - .232 .096 
BIA .705** .736** .742** .232 - .700 
US .543* .673** .637** .096 .700** - 
*p < .05, **p < .01 
BMI had no significant and low correlations to all three WC sites.  BIA showed a highly 
significant relationship to all three WC sites (WC1 r = .705, p = < .01, WC2 r = .736, p = 
< .01, WC3 r = .742, p = < .01).  All three WC sites (WC1 r = .543, p = < .01, WC2 r = 
.673, p = < .01, WC3 r = .637, p = < .01) had significant but moderate correlations to US.  
For BMI the H0 is accepted for all three WC sites.  For BIA and US the H0 is rejected for 
all three WC sites.  Table 7 shows the r values for obese (BMI ≥ 30) males. 
Table 7. all obese (BMI ≥ 30) males, n = 17 
Variable WC1 WC2 WC3 BMI BIA US 
WC1 - .930** .920** .931** .900** .620** 
WC2 .930** - .986** .907** .879* .760** 
WC3 .920** .986** - .893** .846** .780** 
BMI .931* .907** .893** - .866** .640** 
BIA .900** .879** .846** .866** - .692** 
US .620** .760** .780** .640** .692** - 
*p < .05, **p < .01 
BMI was high to very highly correlated (WC1 r =  .931, p = < .01, WC2, r = .907, p = < 
.01, WC3 r = .893, p = < .01) to all three WC sites.  BIA to WC1 was significant and 
very highly correlated (r = .900, p < .01). WC2 (r = .879, p = < .01) and WC3 (r = .846, p 
= < .01) had significantly high correlations to BIA.  Moderate to high significant 
correlations were found between all three WC sites (WC1 r = .620, p < .01, WC2 r = 
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.760, p = < .01, WC3 r = .846, p = < .01) to US. The H0 is rejected for BMI, BIA, and US 
for all three WC sites.  Table 8 displays the r values for the females as one group. 
Table 8. all females, n = 39 
Variable WC1 WC2 WC3 BMI BIA US 
WC1 - .956** .270 .933** .516** .585** 
WC2 .956** - .257 .879** .508** .631** 
WC3 .270 .257 - .150 .106 .178 
BMI .933** .879** .150 - .486** .415** 
BIA .516** .508** .106 .486** - .370* 
US .585** .631** .178 .415** .370* - 
*p < .05, **p < .01 
WC1 (r = .933, p = < .01) and WC2 (r = .879, p = < .01) were significant and very high 
and highly correlated to BMI.  WC1 (r = .516, p = < .01) and WC2 (r = .508, p = < .01) 
were significant and moderately correlated to BIA.  WC1 (r = .585, p = < .01) and WC2 
(r = .631, p = < .01) were significant but moderately correlated to US.  For BMI, BIA, 
and US the H0 is rejected for WC1 and WC2.  For BMI, BIA, and US the H0 is accepted 
for WC3.  BMI with WC1 or WC2 can be used together.  Overweight (BMI ≥ 26 – 29.9) 
female group r values are presented in table 9.   
Table 9. all overweight (BMI ≥ 26-29.9) females, n = 23 
Variable WC1 WC2 WC3 BMI BIA US 
WC1 - .865** .845** .740** .507* .584** 
WC2 .865** - .953** .675** .420* .674** 
WC3 .845** .953** - .638** .257 .604** 
BMI .740** .675** .638** - .546* .417* 
BIA .507* .420* .257 .546** - .396 
US .584** .674* .604** .417** .396 - 
*p < .05, **p < .01 
WC1 (r = .740, p = < .01) showed a significant high correlation to BMI.  WC2 (r = .675, 
p = < .01) and WC3 (r = .638, p = < .01) were significantly but moderately correlated to 
BMI.  WC2 (r = .420, p = < .05) had a significant but low correlation to BIA, while WC1 
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(r = .507, p = < .05) had a significant but moderate correlation to BIA.  All three WC 
sites (WC1 r = .584, p = < .01, WC2 r = .674, p = < .01, WC3 r = .604, p = < .01) had a 
significant but moderate correlation to US.  For BMI the H0 is rejected for all three WC 
sites.  For BIA the H0 is rejected for WC1 and WC2 but accepted for WC3.  For US the 
H0 is rejected for all three WC sites.  Table 10 shows the r values for the obese (BMI ≥ 
30) female group. 
Table 10. all obese (BMI ≥ 30) females, n = 16 
Variable WC1 WC2 WC3 BMI BIA US 
WC1 - .943** .135 .927** .721** .305 
WC2 .943** - .117 .881** .713** .312 
WC3 .135 .117 - -.022 .081 .062 
BMI .927** .881** -.022 - .778** .111 
BIA .721** .713** .081 .778** - .167 
US .305 .312 .062 .111 .167 - 
*p < .05, **p < .01 
WC1 (r = .927, p = < .01) was significant and very highly correlated to BMI and WC2 (r 
= .881, p = < .01) was significant and highly correlated to BMI.  WC1 (r = .721, p = < 
.01) and WC2 (r = .713, p = < .01) were significantly highly correlated to BIA.  All three 
WC sites had non-significant low relationships to US.  WC3 had non-significant and low 
relationship with all variables.  For BMI and BIA, the H0 is rejected for WC1 and WC2 
but accepted for WC3.  For US the H0 is accepted for all three WC sites.  BMI with WC1 
or WC2 can be used together. 
Summary 
 For BMI the sample as an entire group and all the male categories should utilize 
BMI with WC2.  Females as a group or broken down to categories can use BMI with 
WC1 or WC2.    
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The sample as one group WC2 was the only site to have a significant moderate 
relationship to US so WC2 should be used for a group.  For males WC2 works with all 
males, overweight and obese males, but WC3 had a slightly larger correlation to obese 
males and males as an entire group.  For females as a group and as the overweight 
category, WC2 should be utilized.  In the female obese group, there was no significant 
relationship to any of the variables.  WC2 appears to be the best WC measurement 
overall for this sample.   
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Chapter 5 
Discussion 
The main purpose of this study was to see if a relationship existed between the 
visceral fat depth from an ultrasound measurement and the trunk measure from BIA to 
the three different waist circumference sites used.  This chapter discusses the results from 
this study as they relate to the current literature.   
Results 
For the population as a group, WC1 showed no correlation to US which is in 
disagreement with other authors who claim that WC taken at the lowest palpable rib 
(WC1) may be best for identifying cardiometabolic disease risk based on VAT deposition 
patterns (Serviente & Sforzo 2013,Willis et al., 2007).  In this study WC just below the 
lowest palpable rib showed a significant but no correlation (r = .253, p < .05) to US and a 
non-significant (r = .166) relationship to BIA.  WC2 at the level of the umbilicus had the 
highest correlation (r = .862, p = < .01) to BMI and WC2 was the only one of the three 
sites to have a significant but low correlation (r = .415, p = < .01) to BIA and a 
significant but moderate correlation (r = .531, p = < .01) to US in this sample n = 72.  
WC2 is also not recommended by many organizations such as ACSM, AHA, NHLBI, 
NIH and the WHO (ACSM, 2010; Cornier et al., 2011; IDF, 2006; NHLBI, 1998; NIH, 
2000; WHO, 2008).  WC2 was also the only WC site to have a significant but low 
correlation (r = .415, p < .01) to BIA in the same sample n = 72.  In this study WC just 
below the lowest palpable rib showed a significant but no correlation (r = .253, p < .05) 
to US and a non-significant (r = .166) relationship to BIA. 
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When the sample is broken down to overweight and obese categories the 
overweight group for BMI should be paired with WC2 due to having the highest 
correlation (r = .571, p = < .01) and again WC2 had the only significant but low 
correlation (r = .350, p = < .05) to US.  For an overweight population it appears that the 
level of the umbilicus (WC2) should be used which again is not recommended by a few 
major organizations.  The obese group for BMI also had WC2 being the best match with 
highest correlation (r = .867, p = < .01) and BIA (r = .609, p = < .01) and US r = .518, p 
= < .01) as well.  BIA also had the most significant but still moderate correlation (r = 
.609, p = < .01) to WC2 in the all obese group, which are in a disagreement with Segal et 
al., 1988 who claim being obese or severely obese is a limitation when using BIA 
because it consistently overestimated lean body mass in severely obese people.  This may 
still be true for total body fat estimation but for trunk estimation BIA in an obese 
population had the strongest agreement with US.  
The all males group BMI should be paired with superior to the iliac crest (WC3) 
or WC2, which WC3 is in agreement with ACSM, AHA, and the NIH recommendations.  
BIA appears to work well in estimating trunk fat percentage at all three WC sites.  WC2 
(at the level of the umbilicus) and WC3 (superior to the iliac crest) had significant high 
correlations to US (WC2 r = .779, p = <	.01, WC3 r = .785, < .01) that again agree with 
ACSM, AHA, and the NIH recommendations in regards to choosing superior to the iliac 
crest.  All three WC sites had moderate significant correlations in the male combined 
sample (WC1 r = .686, p = < .01; WC2 r = .779, p = < .01; WC3 r = .785, p = < .01).  
This is in agreement with Kuk et al., 2006 who only had a male sample and CT scans 
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from Lumbar 1- Lumbar 3 showed the highest correlation (R2  = 0.96, P < 0.05) with 
total volume of fat and lower SEEs than all other images taken by CT scans from T11-S1.   
When the all male sample is broken down into overweight and obese categories 
the overweight category had no significant correlations with any three WC sites but all 
relationships were low.  BMI can be used with any of these three WC sites but note only 
a low relationship was found.  BIA had similar correlations for all three WC sites, which 
agrees with Segal et al., 1988 whom claim obese or severely obese is a limitation when 
using BIA and in this overweight sample BIA relationships are similar in all 3 WC sites.  
WC2 and US had the strongest and significant correlation (WC2 r = .736, p = < .01) so 
WC2 is recommended for overweight males.  For obese males BIA had a very high and 
significant correlation to WC1 (r = .900, p = < .01) and high correlations to WC2 (r = 
.879, p = < .01) and WC3 (r = .846, p = < .01).  These results are in disagreement with 
Segal et al., 1988 who claim being obese or severely obese is a limitation when using 
BIA because it has consistently overestimated lean body mass in severely obese people.  
For a dominant male sample maybe a lower WC measurement would be better.  This 
could be due to males tending to develop android obesity.   
The all female group also had WC2 having the highest significant moderate (r = 
.631, p = < .01) correlation to US.   
WC3 superior to the iliac crest had no significant relationship to BIA, BMI or US.  
This was the lowest WC measurement so it may be that measuring to low on the torso 
may show no relationship to actual VAT. As a group sample mixed with males and 
females, this study suggest using the WC site at the level of the umbilicus.   
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In the male only samples, both groups overweight and obese BMI found WC2 
having the highest US correlation with WC3 next followed by WC1.  The correlation 
with BIA was highly significant in all male groups with obese with WC1 having the 
highest correlation (r = .900, p = < .01) in this study which agrees with Willis et al., 2007 
who claim that the lowest palpable rib may be best for identifying cardiometabolic 
disease risk based on VAT.  These results are in disagreement with Segal et al., 1988 who 
claim being obese or severely obese is a limitation when using BIA because it has 
consistently overestimated lean body mass in severely obese people.  For a dominant 
male sample maybe a lower WC measurement would be better.  This could be due to 
males tending to develop android obesity.   
In the all female group only WC1 and WC2 had relationships to BMI, BIA or US.  
WC3 had no significant relationship to any of the variables as a group.  BMI should be 
paired with WC1 due to the significant and high correlation (r = .933, p = < .01) to BMI.  
WC3 had no relationship to BIA or US for the all female group so its possible that higher 
WC sites may be more useful in this population.  This could be due to the way females 
store fat.  WC at the umbilicus (WC2) had the strongest significant but moderate 
correlation (r = .631, p = < .01) to US.  When the females were broken down into the 
overweight and obese BMI, BMI and WC1 continued to have the strongest correlations (r 
= .740, p = < .01) and BIA ((r = .507, p = < .05).  However, for US, WC2 had the 
strongest and significant relationship (r = .674, p = < .01).  The obese group for females 
WC1 had the highest and significant relationships to BMI (r = .927, p = < .01) and BIA (r 
= .721, p = < .01) while US had no relationship to any of the WC sites. This could be due 
to body fat distribution being a gynoid type.   
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Future Research directions 
 Future research should include a larger sample size with age and possibly 
ethnicity as additional variables to see if the correlations are strengthened or weakened.  
This research only included the three main WC sites so midway between the lowest rib 
and the iliac crest and minimal waist should be investigated as well.  The gender 
difference in the present study suggests future research to determine if different WC sites 
should be researched for males and females.  For men it appears as weight is gained 
lower WC sites should be used.  Overweight and obese males had stronger relationships 
at the lowest WC site used.  Studies looking at overweight and especially obese females 
should look into below the lowest palpable rib; midpoint between the lowest rib and the 
iliac crest and minimal waist to see what relationships may exist.  It is possible for this 
group that higher up on the torso maybe better to use.  This study also combined all levels 
of obesity into a single group.  Since US found no relationship to any site it is possible 
that the different levels of obesity in males and females need to be conducted to see what 
kind of relationships may exist.   
Conclusion 
 The results of this study show that WC at the level of the umbilicus (WC2) with 
or without BMI is recommended for this college student sample of males and females 
ages 18-55 years old, due to the relationships with BMI, BIA and US that were observed.  
There was a gender effect and males may require lower WC sites and females may 
require higher WC sites.  This gender effect may possibly be due to body fat distribution 
differences.  To add to or strengthen these results, it seems worthy to conduct a larger 
scale study to include the various levels of obesity with all five WC sites and to also 
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include ethnicity as well.  This chapter presented a discussion of the results and how they 
relate to the current literature.  This research is a step forward towards providing a 
standard for a WC protocol. 
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continuation of the project (contact OGRD for procedure).  If, subsequent to initial 
approval, a research protocol requires minor changes, the OGRD should be notified of 
those changes.  Any major departures from the original proposal must be approved by the 
appropriate review process before the protocol may be altered.  A Change of Protocol 
application must be submitted to the IRB for any substantial change in the protocol.  The 
Director, Grant and Research Development, or the Chair of the IRB will determine 
whether or not the research must then be resubmitted for approval. 
 
If you have additional questions please contact me at 359-7039; fax 359-2474: email: 
skeller@ewu.edu.  It would be helpful if you would refer to HS-4936 if there were further 
correspondence as we file everything under this number.  Thank you. 
 
cc: C.Brewer 
 R.Galm 
 W.Repovich 
 Graduate Office 
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Appendix 2: Informed Consent 
 
 
Informed consent form 
 
“Determining the relationship between three waist circumference measures,  
BIA trunk percent fat, and ultrasound abdominal fat depth” 
 
In partial fulfillment of Master’s Thesis for Austin Nelson 
 
Principal Investigator                               Responsible Project Investigator 
Austin Nelson                                          Wendy Repovich, Ph.D., FACSM 
1110 E. Cozza Dr Spokane,WA 99208   Physical Education, Health and Recreation Dept.  
253-250-1219                                           200 Physical Education Bldg. 
ausnelson@comcast.net                          Cheney, WA 99004-2476 
 
Purpose and Benefits  
Obesity and being overweight have several health implications such as risk for type 2 
diabetes, cardiovascular disease, hypertension, high cholesterol, and certain forms of 
cancer that result in premature death. Various methods have been used to assess risk, but 
there has been no standardization of measurement of the waist circumference.  
identifying obese and overweight people is important.  The purpose of this study is to 
determine the relationship between any of the three main waist circumference sites, 
ultrasound measures of abdominal fat depths and Bioelectrical Impedance measure of 
trunk percent fat to recommend a preferred measurement location. 
 
Procedures  
You will come to the Human Performance Lab at Eastern Washington University 
where the following measurements will be taken. You will need to wear clothing that 
will allow measurements of the abdomen. 
1) Your height and weight will be measured using a physician’s scale with a 
stadiometer to determine BMI. 
2) Your waist circumference will be measured at three sites using a Gulick 
measuring tape.  The sites are superior to the iliac crest, level of the umbilicus, 
and right below the lowest palpable rib. 
3) The body fat percentage of your abdomen will be measured using bioelectrical 
impedance analysis on a machine (resembling a scale) that uses a measure of 
electrical impedance to estimate % body fat of the trunk. 
4) Your total, visceral, and subcutaneous fat depths will be measured by an 
ultrasound machine. A dime-sized amount of ultrasound gel will be placed on the 
wand which will then be placed on the abdomen to the right of the umbilicus and 
the scan will be performed by moving the wand 7-10 cm across the skin toward 
the right hip. 
 
Risk, Stress or Discomfort 
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There is minimal risk of an allergic reaction to the ultrasound gel. All equipment will 
be cleaned before and after each use. Body composition results may cause some stress 
for individuals.  Lifestyle counseling will be available for my benefit at the time of 
the measurements if needed. 
 
Inquiries 
Any questions about the procedures used in this study are encouraged.  If you have 
any concerns, questions, or would like more information please contact Wendy 
Repovich or Austin Nelson prior to signing the informed consent form.  We can be 
reached at (509)359-7960; wrepovich@ewu.edu and (253) 250-1219 
ausnelson@comcast.net respectively. 
 
Other Information 
If you have any concerns about your rights as a participant in this research or any 
complaints you wish to make, you may contact Ruth Galm, Human Protection 
Administrator, (509) 359-6567 or rgalm@ewu.edu 
 
 
 
 
            
Signature of Principal Investigator                                                        Date 
 
Subject Statement 
My participation in this study is completely voluntary.  I am free to refuse participation 
and to stop at any point in this study. I understand the study procedures that I will 
perform, and the possible risks that go along with the testing and training.  Knowing all 
of the risks and discomforts, and being allowed to ask questions that have been answered 
to my satisfaction, I consent to take part in this study.  I am not waiving my legal rights 
by signing this form.  I understand I will receive a signed copy of this consent form. 
 
 
 
 
 
                                                  
Signature of Participant        Date 
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Appendix 3:   
 
Data Collection Sheet 
 
________________________ 
Name 
 
 
Male or Female (circle) 
 
 
_________  
Height 
 
_________ 
Weight 
 
 
_________ 
BMI score 
 
 
__________ 
BIA % trunk fat 
 
 
WC site 1______________  2______________3_______________ 
 
 
 
Ultrasound VAT depth –  
 
Notes - 
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